How to be a better investor: episode 3

--  |   28/08/2020 Text size  Decrease  Increase   |  
<p><strong>Ruslan: </strong>What&rsquo;s the difference between a financial service and a financial product?<br /><br /><strong>Saf: </strong>A&nbsp;financial <em>product</em>&nbsp;is something you buy and own, like stocks.<br /><br /><strong>James: </strong>A&nbsp;financial <em>service</em>&nbsp;is when someone performs an action for you that you would otherwise have to do yourself or leave undone, like your taxes<br /><br /><strong>Ruslan: </strong>Ok. I want to buy life insurance to protect my family after I pass, but I don&rsquo;t understand the terms and conditions, so I use a financial advisor. That&rsquo;s a&hellip;&hellip; <em>(Pauses uncertainly)<br /><br /></em><strong>Saf: </strong>The advice is the service.<br /><br /><strong>James: </strong>The insurance is the product.<br /><strong><br />Ruslan: </strong>This is confusing. Which do I need?<br /><br /><strong>Saf + James: </strong>Both<br /><strong><br />Ruslan: </strong>Argh! How do I know if it&rsquo;s worth it!<br /><br /><strong>Saf: </strong>Well, there&rsquo;s ways to make sure you get value from both. When vetting financial products there&rsquo;s two rules.<br /><br />Rule 1: DON'T buy anything you can&rsquo;t explain in your own words<br />Rule 2: Know <em>why</em> you&rsquo;re buying it &ndash; and compare, compare, compare!<br /><br /><strong>Ruslan: </strong>What about service<br /><br /><strong>James: </strong>Ask questions. Lots of questions.<br /><br /><strong>Ruslan: </strong>Like what?<br /><br /><strong>James:</strong> How is your advisor getting paid? An hourly fee? Commissions? Something else? If they&rsquo;re being paid based on what you buy, then are they selling you what&rsquo;s best for you? Or what makes them the most money?<br /><br /><strong>Ruslan: </strong>Ohhhhh.<br /><br /><strong>James: </strong>Yep.<br /><br /><strong>Ruslan: </strong>Wait. What about the advisor from my bank?<br /><br /><strong>James: </strong>Ah. See, he&rsquo;s an advisor that also sells products. Make sure you&rsquo;re being shown more options. Not just the products from their bank. You have to look out for you!</p> <p>&nbsp;</p> <p>&nbsp;</p> <p><strong><em><br /><br />Additional Reading:<br /><br /></em></strong><strong>Don&rsquo;t Get Hosed When Buying Financial Products and Services<br /><br /></strong>Way back in another life, I worked in the mortgage department of a local bank running credit reports for mortgage preapprovals. I heard a lot of unfamiliar terms while working there, but the one that was the strangest and most puzzling to me was "financial product." The idea that a loan could be considered a product was completely foreign. The house was a product, clearly, but the mortgage? It made my head spin.<br /><br />In the years since, I've come to understand how mortgages really are products. Each type of mortgage has different attributes and ways that it "works." In this way, a mortgage is just like any other product on a shelf. Each is devised to meet a certain need and has specific traits that you as a customer can use to distinguish between them and choose which best suits your purposes. But here's the thing: Many people I talk to don't know the difference between a financial product and a financial service, and that's a problem.<br /><br />Products and services are regulated differently, and that can have a big impact on you as a customer. In countries like Singapore, for example, all financial products go through a deep vetting process where the regulating body determines if the terms and conditions are fair and meet a baseline standard of safety for the average investor. The process is slow, and it results in fewer options for customers, but it does provide a bit of protection for the uninitiated since there are few, if any, predatory products available. However, it requires a lot of resources to oversee this process, and one could argue it is too much regulation for a free market system. <br /><br />In North America, our markets are based on the principle of "caveat emptor," or "buyer beware." In other words, the responsibility of determining if a product is beneficial or predatory is placed mainly on you, the buyer.<br /><br />For this reason, in the United States, products are regulated mostly on the basis of disclosure. Companies that sell financial products are required to disclose the terms and conditions of those products to the customer. You know those impenetrable documents of legalese that you have to "read" before signing your mortgage or buying stock? Yup, that's what passes for open and transparent disclosure of a product. If, after being offered the disclosure, you still sign the agreement and get hosed, then it's caveat emptor, my friend. Caveat emptor.<br /><br />So, let's say you want to buy life insurance to protect your family's lifestyle in the event of your untimely demise. You begin to read the disclosures for a few products, and it becomes clear that you could use some help understanding the terms and differences. So, you hire a financial advisor to help you. Now, advice is a service, and services are regulated differently than products.<br /><br />Services are regulated on the basis of qualifications and&nbsp;<a href="">conflicts of interest</a>, but that doesn't mean that just because an advisor has a certification of some sort that he is going to put your best interest first. There are plenty of firms that blur ethical lines, push limits, and then there are flat-out fraudsters who have not yet been caught. When you hire an advisor, you can't depend on&nbsp;<a href="">the government</a>&nbsp;to have completely vetted his trustworthiness. You still need to adhere to the idea of "buyer beware<em>."</em>&nbsp;One of the ways you can beware when vetting financial advice is to have a clear understanding of how the person you are hiring gets paid. Knowing that can help you understand his financial incentive. <br /><br />Imagine walking into a clothing store where the salespeople earn a commission on everything you buy and saying, "I know nothing about clothes or style. Please just tell me what I should buy, and I'll take it." You would never do that! Not because the salespeople aren't good at what they do or don't deserve the commission--that's not the point. The point is that they are incentivized by the company that they work for to sell you the most expensive wardrobe you will accept. We all know this model. There's nothing wrong with it, but as a shopper you generally want to avoid leaving the bulk of your decision in the hands of someone who has that kind of incentive. If your goal is to get a good wardrobe at a decent price, you shouldn't leave 100% of the decision in the hands of the salesperson. It's just not smart. The same thing goes for financial products and services.<br /><br />Sometimes, it can be hard to tell whether someone is a salesperson or a serviceperson, and sometimes one person will play both roles. For example, when you visit the doctor and he diagnoses your illness, that's a service. If he then suggests that you buy a particular brand of medicine, that's a product. If you knew that the doctor received a commission if you buy the drug, would you weigh the advice differently?<br /><br />Similarly, you may hire a financial advisor to help you create a plan to get from here to retirement. You discuss strategies for saving, investing, and what your life goals are. The advisor helps you understand the steps necessary to achieve them. This is a service.<br /><br />If that same advisor sells you a life insurance policy and several mutual funds, these are products. The advisor has now switched roles from serviceperson to salesperson. There is nothing wrong with this, just as with a doctor or a hair stylist recommending a particular brand. You, the customer, simply need to know what you're buying, and how the incentives are structured so that you can weigh the product recommendations accordingly.<br /><br />So, then, what's the smart shortcut for identifying and vetting financial advice and products? First, let's talk about simple definitions for each. Since these are rules of thumb, they aren't exact or perfect, but we're all about being "<a href="">good enough</a>"&nbsp;here.<br /><br />A&nbsp;<em>financial product</em>&nbsp;is something you buy (including contractual agreements like loans) and take ownership over, along with the responsibility for complying with the terms of ownership. Examples are checking and savings accounts, stocks, funds, mortgages, and insurance policies.<br /><br />A&nbsp;<em>financial service</em>&nbsp;is when someone performs an action for you that you would otherwise have to do yourself or leave undone. Most often in the financial profession, services involve the application of expertise. Examples are financial planning, investment advice, tax preparation, and legal consultation.<br /><br />Rules of thumb for vetting quality are a bit tougher, but here's my best shot:<br /><br />When vetting financial products:<br />1) Don't buy anything you can't explain clearly in your own words.<br />2)&nbsp;Decide on a few attributes that matter most to you and compare at least a few options. For example, when comparing shares of stock, you may care most about past performance and strength of the brand. With loans, you may care most about the interest rate and whether or not there is a prepayment penalty. If you can't name at least a couple of product attributes that matter to you, then you don't understand it well enough (see number 1).<br /><br />When vetting financial services:<br />1) Understand how the person gets paid. Does the advisor charge an hourly fee? Earn commissions on sales? Take a percentage of earnings? Some combination of those? Then make some decisions about how the financial incentives might affect the services rendered and adjust your cost-benefit analysis accordingly.<br />2) If you are working with an advisor who also sells products, make sure that you are being shown more options than just the ones they sell. If you are paying for expertise to help you make the right choice of investments for your needs, then you should know that you are being shown the full menu, so to speak, and not only the few options that they are selling.<br /><br />Bottom line: Financial products and services can be confusing and often purposefully opaque, but the responsibility of protecting your own interests while navigating this landscape falls on you, the buyer. Knowing the difference between financial products and services is a first step in vetting the advice you receive and the products you are shown. It's your responsibility, so remember that, and caveat emptor!<br /><br /><em>The additional reading is by Sarah Newcomb, a member of Morningstar's Behavioural team.</em></p>

Video Archive...

3 top picks for the EV revolution
18/09/2020  Morningstar's Seth Goldstein singles out three undervalued stocks that span the entire electric vehicle supply chain.
The 2020 election and your portfolio
18/09/2020  The bumps and bruises of election time may tempt you to shift your portfolio strategy.  
'The tech rally has gone too far'
17/09/2020  UK-based Premier Miton's Simon Evan-Cook says the tech rally of 2020 is reminiscent of the dotcom boom, but inflation could be a bigger threat.
Why EVs will be a common sight on the roads of the future
16/09/2020  By 2025, the cost of batteries and manufacturing will fall and EV functionality will improve, says Morningstar's Seth Goldstein.
Using personal data to better estimate retirement savings
11/09/2020  Estimating the length of your retirement with personalized information will help you save the correct amount.
2 China stocks we like
09/09/2020  Morningstar's Chelsey Tam reveals which stocks and sectors have shone—and which have underwhelmed.
How to be a better investor: episode 3
28/08/2020  Products, services, what is what in the world of finance—and how to look out for yourself
Where to invest for income
24/08/2020  A raft of companies have cut their dividends this year, leaving income investors concerned. But Morningstar's Dan Lefkovitz says there are still plenty of options out there.
DNR Capital's eye for gaming, building supplies and software
18/08/2020  DNR Capital's chief investment officer Jamie Nicol profiles some of the top ten holdings in his Australian Equities High Conviction fund. 
The trouble on Telstra's horizon
17/08/2020  Morningstar's Brian Han explains why he has trimmed his fair value estimate for Australia's dominant telco and the future of its dividend payout.
Finding bargains the market overlooks
14/08/2020  DNR Capital's Jamie Nicol reveals how his Australian Equities High Conviction fund finds quality businesses that will endure difficult conditions.
How to be a better investor: episode 2
13/08/2020  Put your money to work if you're looking for financial freedom.
How to be a better investor: episode 1
10/08/2020  Learn how to picture your goals so you can better reach them.
3 undervalued names in childcare
05/08/2020  Morningstar's Gareth James identifies three sector names trading at attractive discounts in an increasingly 'essential' sector.
Is the 60/40 portfolio dead?
05/08/2020  Reports of the strategy's demise are greatly exaggerated, says Morningstar's Christine Benz.
Why you should ignore a fund's yield
04/08/2020  Investors may assume a fund's yield to determine how much income it will pay, but it's not always so simple, warns Morningstar analyst Rajesh Yadav.
What are the right bonds for retirees today?
03/08/2020  It depends on your expectations and timeframe. Look at bonds as being portfolio stabilisers—sources of cash flow you can draw on when your equities are down, says Christine Benz.
3 top picks in rail, roads and utilities
28/07/2020  When utility stocks plunged during the onset of the pandemic Lazard Asset Management's Warryn Robertson knew it was time to jump in.
Infrastructure stocks in the covid era
24/07/2020  Lazard Asset Management's Warryn Robertson looks at how the pandemic has affected toll roads and airports and what the future of travel holds.
ESG stocks shine in covid-19 crisis
23/07/2020  Morningstar analyst Tancrede Fulop singles out a few companies that have performed well and also led the way in looking after staff. 
Stock-picking: Have you got what it takes?
21/07/2020  New stock-pickers are prone to lose money. Are the lessons worth the price? We ask Morningstar's Christine Benz.
Why mining stocks aren't yield plays
20/07/2020  Elevated iron ore prices have lifted mining company earnings to eye-watering levels but this doesn't make them income stocks, says Morningstar's Mat Hodge.
Commodity stocks riding high, but for how long?
17/07/2020  Local miners should deliver stellar fiscal 2020 results but such outperformance is unlikely to last, says Morningstar’s Mat Hodge.
The rise and rise of Amazon
17/07/2020  --
Should your portfolio shift when the economy slumps?
16/07/2020  How to make some upgrades during this down time.
Will Airbnb IPO or what?
16/07/2020  Covid-19 has made the intended public offering impossible, says Morningstar's Andrew Willis.
3 Japanese stock picks
15/07/2020  JPMorgan's Nicholas Weindling talks opportunities in Japan and reveals the stock that has been his largest holding for almost a decade
Small cap stocks: 'Inevitably, we see it all end in tears'
15/07/2020  The asset class has a habit of outperforming but Morningstar's Ross MacMillan sees signs of a bubble.
A trio of growth stocks
13/07/2020  Rachel Winter of UK fund manager Killik & Co talks payments, social media and investing in her monthly stock pick round-up
3 reasons healthcare is showing fit performance
09/07/2020  And what we expect to see moving forward.
Same old story: growth beats value
07/07/2020  Large growth maintains its supremacy in the Morningstar Style Box during a volatile first half for mutual funds. 
Nikko's 3 top Asian picks
06/07/2020  Nikko Asset Management's Peter Monson looks for strong sustainable returns and he sees that in Asian stocks that span financial exchanges, computer game makers and condiments suppliers.
How appealing are Asian stocks?
02/07/2020  China’s ongoing recovery from COVID-19 presents solid investment opportunities, says Nikko Asset Management.
'Unemployment will be higher, activity lower'
01/07/2020  Aviva Investors' Mark Robertson on the 'second wave', the widening gap between the West and China, portfolio protection and how covid has accelerated the tech revolution.
Smartwatches and luxury watches battle for your wrist
29/06/2020  Does the rise in smartwatches show that data, not diamonds, are a girl's best friend?
3 top picks in water and waste
26/06/2020  They may be 'boring' says Fidelity's Bertrand Lecourt but these names offer solid and long-term returns by delivering essential services.
Tapping opportunities in water and waste
25/06/2020  The growing consumption of water and the increased production of waste make these sectors compelling investments, says Fidelity's Bertrand Lecourt.
Dividends: ‘You have to be very active in stock selection’
23/06/2020  Yield can still be found among global healthcare, technology and consumer staples despite the dismal dividend outlook, says Janus Henderson’s Jane Shoemake.
Airlie went shopping during COVID sell-off
22/06/2020  COVID has given consumers the "fright of their lives" but this fund manager took the opportunity to scoop up bargain bluechips, says portfolio manager Matt Williams.
3 top picks: miner, insurer, fueler
19/06/2020  Mineral Resources, Medibank Private and Ampol are among Airlie Fund Management's preferred stocks, says portfolio manager Matt Williams.
Retail bonanza can’t last, warns Morningstar
16/06/2020  Investors shouldn’t project the pandemic-driven performance of JB HiFi and Harvey Norman too far into the future.
3 Aussie equities to watch
11/06/2020  Lazard Asset Management's Philipp Hofflin explains why mortgage processing, insurance and aluminium production are on his radar.
Are value stocks due for a comeback?
10/06/2020  Value investing has massively underperformed growth over the past decade. Christine Benz talks with Alex Bryan about the fundamental case for value.
3 top picks for a covid crisis
05/06/2020  Specialist consulting firms and chocolate bars. It's a disparate mix but Ned Bell of Bell Asset Management has good reason for seeing value in these sectors right now.
What the share market is missing
04/06/2020  Earnings results will be a rude awakening, says Ned Bell of Bell Asset Management, but there is nevertheless value among some global small- to mid-cap stocks.
The dividend balancing act
03/06/2020  Ensure your dividend-paying companies are more than attractive on the surface with these tips from Morningstar Canada's director of investment research, Ian Tam, CFA.
How dividend-paying stocks fit into retiree portfolios
01/06/2020  Christine Benz suggests retirees should take a balanced approach to these strategies.
Casino comeback and the uncertainty engulfing Seven West
29/05/2020  Most punters would prefer to lose money with their friends in a real casino than gambling online alone in their basement, says Brian Han.
The WFH reality-check for REITs
28/05/2020  Working from home means upheaval for office landlords but shopping mall owners are enjoying the end of hibernation, says Morningstar's Brian Han.
An undervalued, wide-moat name in healthcare
27/05/2020  Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.
5 investing mistakes to avoid
20/05/2020  Christine Benz discusses pitfalls investors encounter as they navigate volatility and recovery.
Ugly housing outlook won’t last
19/05/2020  Adelaide Brighton, Amcor and Bingo should ride out the housing construction slump with relative ease, says Morningstar’s Grant Slade. 
3 stocks set to clean up
18/05/2020  The biggest corporate hygiene company you never heard of; Dettol's parent company; and a lab supplier are tipped to benefit post-coronavirus.
Greencape's three top picks
13/05/2020  Property listings, software for financial planners and AI machine-learning: Jonathan Koh has scoured the globe for opportunities.
Where to hunt when guidance statements get torn up
12/05/2020  Greencape Capital entered the downturn with a cash reserve that has allowed it to snare some essential services companies at bargain prices, says Jonathan Koh.
Investing basics: the hardest decision in investing
08/05/2020  When and how should you get back into equity markets after panic selling?
Weighing up Australia’s banks
07/05/2020  Bad debts and expected capital raising from three of the big four cloud the outlook for Aussie banks, says Morningstar's Nathan Zaia.
Surprises from Berkshire's annual meeting
05/05/2020  Morningstar's Gregg Warren discusses the meeting's cautious tone, Berkshire's lack of buying during the downturn, and unloading the airlines.
Banks will see out corona crisis
04/05/2020  Loan defaults, shaky house prices and a dividend pause - it's ugly in the short term but Nathan Zaia has long-term faith in Australia's banks.
What the pandemic means for Berkshire Hathaway
30/04/2020  Gregg Warren shares his thoughts on its valuation and more.
Netflix steals the show but for how long?
29/04/2020  What happens when the lockdown ends? The streaming giant may need to get some serious growth in international markets to make up for investor expectations. 
Unique, but normal: riding out this market crisis
27/04/2020  The markets follow patterns. We discuss ways to find your way to the upside of the current environment.
3 defensive utility stocks
23/04/2020  These utility stocks aren't the cheapest but have solid balance sheets and decent yield potential.
What in the world happened to oil prices?
22/04/2020  Amid such a painful downturn and the ensuing demand shock, it's crucial to consider companies that are in sound financial health, says Dave Meats.
'An apocalyptic asset': owning gold
21/04/2020  Gold can be a useful insurance policy for investment portfolios, says Morningstar analyst Kenneth Lamont, but it's not perfect
Energy crisis will be short-lived
20/04/2020  Will energy majors bounce back from the coronavirus-induced turmoil? You bet they will, says Mark Taylor and here are the names to watch.
What role do bonds play in an era of ultralow yields?
16/04/2020  Investors are right to be questioning bonds' role in their portfolios, but they still serve a useful purpose for many.
US tech sector now decently undervalued
14/04/2020  We examine how this sector handled the market turmoil and what to expect
Will energy stocks rise from the ashes?
09/04/2020  Investors' current concerns are justified, but vast long-term opportunities remain in this significantly undervalued sector.
Corona crisis threatens big four dividends
08/04/2020  The short-term may be scary but the major banks' long-term outlook will withstand the shock, says Morningstar's Nathan Zaia.
What to expect as the virus continues
08/04/2020  Christine Benz and Karen Andersen discuss Morningstar's latest views on stopping the spread of the virus as well as the economic implications.
In volatile markets, it's OK to chicken out
03/04/2020  Christine Benz explains why now isn't the time for grand gestures with your investments; instead, take a light touch to them.
Avoiding all eggs in the same basket
02/04/2020  Get the full effect of diversification by considering the correlation of your assets with these tips from Morningstar's Director of Investment Research, Ian Tam
Coronavirus: stock up on quality companies
01/04/2020  Retail and energy companies rank among Morningstar's sector picks, despite seeing some of the sharpest falls since coronavirus hit.
Is this 2008 all over again?
31/03/2020  Eric Jacobson explains why the banking system is not at the centre of the corona crisis, and in fact, is well positioned to be a tool to help solve it.
The critical reason to stay invested
30/03/2020  Why it's important to stay invested to capture critical months for your portfolio, with Morningstar's director of investment research, Ian Tam
How to avoid dividend cuts
27/03/2020  A wave of companies are expected to cut their dividends amid the coronavirus crisis. Morningstar's Dan Lefkovitz explains how to spot a firm that could its pay out.
Healthcare stocks still defensive, says Morningstar
26/03/2020  Respiratory specialist Fisher & Paykel Healthcare is among stocks now enticingly priced as the coronavirus hits markets and the Aussie dollar.
Cheap or nasty? Seven, Nine and Telstra
24/03/2020  A stock that’s heavily sold down isn’t always a screaming buy, as proven by this comparison of debt and other fundamentals among these well-loved companies.
Mining stocks offer price opportunity, dividend threat
20/03/2020  OZ Minerals, South32 and Iluka are among miners dipping into buy territory amid the coronavirus selloff but dividends are at risk, says Morningstar’s Mat Hodge.
Market, economic implications amid latest virus news
20/03/2020  Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.
'The long-term bounceback will be strong'
17/03/2020  The coronavirus fallout is hurting but there should be a treatment by year end and the rebound will be strong, says Morningstar director of equities Johannes Faul. 
Taking control in time of corona
17/03/2020  In this timely Morningstar panel discussion, but Christine Benz and Andrew Lill provide  concrete tips on how curb your losses and put your money to use.
The importance of staying invested in volatile times
16/03/2020  Don't flee the market in a panic, but rather embrace the turmoil as an investment opportunity—you'll be better off in the long run.
‘A modest sell-off, not a panic’: Douglass on coronavirus fallout
14/03/2020  The Magellan co-founder insists now is not the time to ditch stocks for cash nor to buy bargains, and global businesses won’t turn their backs on China.
Avoid panic-selling: Douglass calls for calm
12/03/2020  Share market speculation is almost always a bad idea, and panic-selling stocks on coronavirus fears is an example of just that, warns Magellan boss.
Coronavirus and the market: our take
11/03/2020  We offer three takeaways and advice on staying true to your goals.
Hits and misses aplenty in first half 2020 - Part 2
10/03/2020  Consumer stock Breville and listed property firm Charter Hall were among the highest gainers after delivering results, while Mayne Pharma and Seven West saw the sharpest falls.
Hits and misses aplenty in first half 2020 - Part 1
09/03/2020  The interim reporting season served up a lesson in why investors shouldn't rely too heavily on company forecasts, says Morningstar's Peter Warnes
The best diversifiers for your equity portfolio
05/03/2020  Christine Benz discusses how to protect your portfolio from a stock-market sell-off.
Green bonds offer another side to ESG investing
05/03/2020  Investors are largely unaware of the role fixed income can play in expressing their views on social, environmental and governance issues.
ETF investing for the new decade: 4 trends to watch
02/03/2020  In only a decade, the value of Australia's ETF market has risen by almost 2000 per cent.
The new medical device company to watch
28/02/2020  Spray-on skin maker Avita Medical has a chance of becoming the new standard in burns treatment, says Morningstar's Nicolette Quinn. 
Helping financial advisers help investors
27/02/2020  Financial advice can deliver value but we must do a better job of showing what that is and measuring it, says Morningstar chief executive Kunal Kapoor.
'ESG is about building a portfolio for outperformance'
26/02/2020  Morningstar CEO Kunal Kapoor explains the importance of ESG investing and why it's not simply a matter of avoiding guns, smokes and booze.
Volatility is here to stay - here's what to do
25/02/2020  Morningstar's director of personal finance Christine Benz explains how investors - young and old - should navigate how the coronavirus, the US election and frothy stock prices.
Why mining dividends are a flash in the pan
24/02/2020  A near-record dividend payout from BHP reflects high iron ore prices and miners flush with cash, but these conditions won’t continue long-term, says Morningstar’s Mat Hodge.
The case for emerging market debt
20/02/2020  Lazard Asset Management's Arif Joshi demystifies emerging market debt and explains why it can offer excess yields.
Telstra faces Vodafone-TPG tie-up
18/02/2020  Morningstar equity analyst Brian Han reckons the Vodafone-TPG is a 75pc chance of proceeding but says there's a risk of overestimating its effect on Telstra.
CBA result puts dividend fears to bed, NAB on track
14/02/2020  Despite a profit dip there are many positives for CBA, including growth in mortgages and deposits and a strong balance sheet, says Morningstar equity analyst Nathan Zaia.